Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol TIVA in TKA
NCT05322902Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in knee osteoarthritis (OA) (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Intraoperative remifentanil consumption. Started Jun 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05322902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322902.